These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3339265)

  • 21. Determination of 8-methoxypsoralen in plasma by scanning fluorometry after thin-layer chromatography.
    Chakrabarti SG; Gooray DA; Kenney JA
    Clin Chem; 1978 Jul; 24(7):1155-7. PubMed ID: 657495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 8-Methoxypsoralen plasma levels and phototoxic effect.
    De Bersaques J; Monbaliu J; Belpaire F; Bogaert M
    Photodermatol; 1984 Apr; 1(2):79-84. PubMed ID: 6531285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of 8-methoxypsoralen after bath-PUVA for psoriasis: relationship to disease severity.
    Gómez MI; Azaña JM; Arranz I; Harto A; Ledo A
    Br J Dermatol; 1995 Jul; 133(1):37-40. PubMed ID: 7669638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comments on the paper by V. Nitsche et al.: 8-Methoxypsoralen (8-MOP) in neuer galenischer Zubereitung und seine Beziehung zum 8-MOP-Serumspiegel. 8-Methoxypsoralen (8-MOP)--a new galenic form and its relation to 8-MOP serum levels.
    Siddiqui AH
    Arch Dermatol Res; 1982; 272(1-2):181. PubMed ID: 7165319
    [No Abstract]   [Full Text] [Related]  

  • 25. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
    Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
    Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 8-MOP plasma levels in PUVA problem cases with psoriasis.
    Wagner G; Hofmann C; Busch U; Schmid J; Plewig G
    Br J Dermatol; 1979 Sep; 101(3):285-92. PubMed ID: 508594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-performance liquid chromatographic determination of methoxsalen in plasma after liquid-solid extraction.
    Kucová D; Marysková D; Davídková P; Gasparic J
    J Chromatogr; 1993 May; 614(2):340-4. PubMed ID: 8314948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of 8-methoxypsoralen in plasma by electron capture gas chromatography.
    Ehrsson H; Eksborg S; Wallin I; Kållberg N; Swanbeck G
    J Chromatogr; 1977 Oct; 140(2):157-64. PubMed ID: 914909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The binding of 8-methoxypsoralen by human serum albumin.
    Veronese FM; Bevilacqua R; Schiavon O; Rodighiero G
    Farmaco Sci; 1978 Sep; 33(9):667-75. PubMed ID: 744263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automated liquid-liquid extraction based on 96-well plate format in conjunction with ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) for the quantitation of methoxsalen in human plasma.
    Yadav M; Contractor P; Upadhyay V; Gupta A; Guttikar S; Singhal P; Goswami S; Shrivastav PS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):167-71. PubMed ID: 18656428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular aspects of extracorporeal photochemotherapy.
    Gasparro FP; Dall'Amico R; Goldminz D; Simmons E; Weingold D
    Yale J Biol Med; 1989; 62(6):579-93. PubMed ID: 2700057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 8-Methoxypsoralen serum levels in poor responders to photochemotherapy. Importance of drug formulation and individual factors.
    Walther T; Haustein UF
    Int J Dermatol; 1991 Jul; 30(7):516-8. PubMed ID: 1769779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of 8-methoxypsoralen in plasma by gas chromatography-mass spectrometry using selected-ion monitoring.
    Cracco AT; Dall'Amico R; Ferrari V; Bottaro S; Zacchello G; Chiandetti L; Zacchello F
    J Chromatogr; 1992 Feb; 574(1):156-60. PubMed ID: 1629281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Methoxypsoralen (Bergapten) for photochemotherapy. Bioavailability, phototoxicity, and clinical efficacy in psoriasis of a new drug preparation.
    Tanew A; Ortel B; Rappersberger K; Hönigsmann H
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):333-8. PubMed ID: 3279089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen.
    Stolk LM; Siddiqui AH; Westerhof W; Cormane RH
    Br J Dermatol; 1985 Apr; 112(4):469-73. PubMed ID: 3994922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoralen-ultraviolet A-induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid.
    Yeo UC; Shin JH; Yang JM; Park KB; Kim MM; Bok HS; Lee ES
    Br J Dermatol; 2000 Apr; 142(4):733-9. PubMed ID: 10792224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro kinetics of 8-methoxypsoralen penetration into human lymphoid cells.
    Karolak L; Tod M; Leon A; Heudes AM; Petitjean O; Laroche L
    Photodermatol Photoimmunol Photomed; 1992 Apr; 9(2):58-60. PubMed ID: 1489716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of metoclopramide on the pharmacokinetics of 8-methoxypsoralen.
    Studer-Sachsenberg EM; Piletta PA; Fathi M; Saurat JH; Salomon D
    Dermatology; 1997; 195(1):81-3. PubMed ID: 9267751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.
    Langner A; Wolska H; Kowalski J; Duralska H; Murawska E
    Int J Dermatol; 1976 Nov; 15(9):688-9. PubMed ID: 977210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pharmacokinetic comparison in dogs of seven brands of 8-MOP and five new formulations.
    Van Boven M; Roelandts R; De Greef H; Kinget R; Adriaens P; Daenens P
    Photodermatol; 1985 Feb; 2(1):27-31. PubMed ID: 3982992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.